Watson makes off with Makoff

Ferrlecit NDA sponsor Makoff R&D Labs will be acquired by Watson in a $185 mil. pooling of interest deal expected to close by the end of the year. Watson subsidiary Schein markets Ferrlecit for iron deficiency anemia in hemodialysis patients